1. Home
  2. JNJ
  3. JNJ News

Latest Johnson & Johnson (JNJ) News on July 26, 2024

Is Johnson & Johnson (NYSE:JNJ) A Risky Investment?
JNJ

Simply Wall St.

12 hours ago

Is Johnson & Johnson (NYSE:JNJ) A Risky Investment?

'Never going to be the same': How Nvidia is trying to revolutionize healthcare
JNJ

Yahoo Finance

a day ago

'Never going to be the same': How Nvidia is trying to revolutionize healthcare

AC Immune wins FDA fast track for Alzheimer’s vaccine candidate
JNJ

Pharmaceutical Technology

a day ago

AC Immune wins FDA fast track for Alzheimer’s vaccine candidate

Sandoz launches ustekinumab biosimilar in Europe
JNJ

Pharmaceutical Technology

a day ago

Sandoz launches ustekinumab biosimilar in Europe

AbbVie (ABBV) Beats on Q2 Earnings & Sales, Ups '24 EPS View
JNJ

Zacks

a day ago

AbbVie (ABBV) Beats on Q2 Earnings & Sales, Ups '24 EPS View

AstraZeneca Posts Earnings Beat, Lifts Guidance on Strong Sales
JNJ

Investopedia

a day ago

AstraZeneca Posts Earnings Beat, Lifts Guidance on Strong Sales

How To Earn $100 Per Month From Johnson & Johnson Stock
JNJ

Benzinga

2 days ago

How To Earn $100 Per Month From Johnson & Johnson Stock

Claimants Face 5pm ET Fri Deadline to Accept $8 Billion Settlement in J&J Suit, Ovarian Cancer Survivors Urge Others to Vote “Yes”
JNJ

Exec Edge

2 days ago

Claimants Face 5pm ET Fri Deadline to Accept $8 Billion Settlement in J&J Suit, Ovarian Cancer Survivors Urge Others to Vote “Yes”

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
JNJ

Zacks

2 days ago

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

J&J forecast to dominate BiTE market
JNJ

Pharmaceutical Technology

3 days ago

J&J forecast to dominate BiTE market

Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
JNJ

Business Wire

3 days ago

Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

J&J drops Addex’s epilepsy treatment after flunking in Phase II
JNJ

Pharmaceutical Technology

3 days ago

J&J drops Addex’s epilepsy treatment after flunking in Phase II

Time for Healthcare ETFs?
JNJ

Zacks

3 days ago

Time for Healthcare ETFs?

Covid-19 vaccines: serious adverse events explained
JNJ

Pharmaceutical Technology

4 days ago

Covid-19 vaccines: serious adverse events explained

5 Best Dividend Stocks For Roth IRA According To Reddit
JNJ

Benzinga

4 days ago

5 Best Dividend Stocks For Roth IRA According To Reddit

J&J Allies With Mass-Tort Specialists to Seal $8 Billion Talc Settlement
JNJ

The Wall Street Journal

4 days ago

J&J Allies With Mass-Tort Specialists to Seal $8 Billion Talc Settlement

JNJ

MT Newswires

4 days ago

Daiwa Downgrades Johnson & Johnson to Neutral From Outperform, Adjusts Price Target to $150 From $160

Johnson & Johnson submits sNDA for SPRAVATO to treat depression
JNJ

Pharmaceutical Technology

4 days ago

Johnson & Johnson submits sNDA for SPRAVATO to treat depression

Achieve Financial Independence with This Dividend Stock in 10 Years
JNJ

Benzinga

4 days ago

Achieve Financial Independence with This Dividend Stock in 10 Years

JNJ

MT Newswires

4 days ago

Sector Update: Health Care Stocks Rise in Monday's Premarket Hours

JNJ

MT Newswires

4 days ago

Johnson & Johnson Seeks FDA Approval for Spravato as Monotherapy for Depression

Beyond Market Price: Uncovering Johnson & Johnson's Intrinsic Value
JNJ

GuruFocus.com

4 days ago

Beyond Market Price: Uncovering Johnson & Johnson's Intrinsic Value

Johnson & Johnson seeks U.S. FDA approval of SPRAVATO® (esketamine) as the first and only monotherapy for adults with treatment-resistant depression
JNJ

PR Newswire

4 days ago

Johnson & Johnson seeks U.S. FDA approval of SPRAVATO® (esketamine) as the first and only monotherapy for adults with treatment-resistant depression

J&J seeks expanded approval for antidepressant Spravato
JNJ

BioPharma Dive

4 days ago

J&J seeks expanded approval for antidepressant Spravato

JNJ

MT Newswires

4 days ago

Guggenheim Adjusts Johnson & Johnson's Price Target to $156 From $160, Maintains Neutral Rating

Possible Bearish Signals With Johnson & Johnson Insiders Disposing Stock
JNJ

Simply Wall St.

7 days ago

Possible Bearish Signals With Johnson & Johnson Insiders Disposing Stock

Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
JNJ

Investor's Business Daily

7 days ago

Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review

JNJ

Argus Research

7 days ago

The Argus Min Vol Model Portfolio

JNJ

Argus Research

7 days ago

The Argus Min Vol Model Portfolio

JNJ

MT Newswires

7 days ago

HSBC Adjusts Price Target on Johnson & Johnson to $174 From $170, Maintains Buy Rating

JNJ

Morningstar Research

8 days ago

Analyst Report: Johnson & Johnson

JNJ

MT Newswires

8 days ago

Johnson & Johnson Shares Trade at Fair Value After Q2 Results, 2024 Guidance, Morgan Stanley Says

JNJ

MT Newswires

8 days ago

Goldman Sachs Adjusts Price Target on Johnson & Johnson to $155 From $160

Company News for Jul 18, 2024
JNJ

Zacks

8 days ago

Company News for Jul 18, 2024

JNJ

MT Newswires

8 days ago

Bernstein Adjusts Price Target on Johnson & Johnson to $171 From $161

3 High Yield Healthcare Giants With Consistent Dividend Growth: Johnson & Johnson, Merck, And Quest Diagnostics
JNJ

Benzinga

8 days ago

3 High Yield Healthcare Giants With Consistent Dividend Growth: Johnson & Johnson, Merck, And Quest Diagnostics

A Top-Tier Dividend Stock Every Passive-Income Investor Should Consider
JNJ

Motley Fool

8 days ago

A Top-Tier Dividend Stock Every Passive-Income Investor Should Consider

JNJ

Argus Research

9 days ago

Analyst Report: Johnson & Johnson

JNJ

Argus Research

9 days ago

Market Digest: JBHT, JNJ, STT, USB, ASML

Is Johnson & Johnson a Buy Now?
JNJ

Motley Fool

9 days ago

Is Johnson & Johnson a Buy Now?

JNJ

MT Newswires

9 days ago

TD Cowen Adjusts Price Target on Johnson & Johnson to $185 From $195, Maintains Buy Rating

JNJ

MT Newswires

9 days ago

Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $167, Maintains Equalweight Rating

Johnson & Johnson’s Q2 2024 net earnings drop 12.8% to $4.6bn
JNJ

Pharmaceutical Technology

9 days ago

Johnson & Johnson’s Q2 2024 net earnings drop 12.8% to $4.6bn

JNJ

Thomson Reuters StreetEvents

9 days ago

Q2 2024 Johnson & Johnson Earnings Call

China chip exports, Fed rate cut optimism: Market Domination
JNJ

Yahoo Finance Video

9 days ago

China chip exports, Fed rate cut optimism: Market Domination

Why Johnson & Johnson Stock Was a Winner on Wednesday
JNJ

Motley Fool

9 days ago

Why Johnson & Johnson Stock Was a Winner on Wednesday

These Stocks Moved the Most Today: Nvidia, AMD, ASML, TSMC, Intel, J&J, Five Below, GitLab, and More
JNJ

Barrons.com

9 days ago

These Stocks Moved the Most Today: Nvidia, AMD, ASML, TSMC, Intel, J&J, Five Below, GitLab, and More

JNJ

MT Newswires

9 days ago

Dow Closes at Record High as Nasdaq Plunges; Markets Parse Fed Governor Remarks, Earnings, Trade Threats

Johnson & Johnson Makes A Bullish Move On A Second-Quarter Beat — With Caveats
JNJ

Investor's Business Daily

9 days ago

Johnson & Johnson Makes A Bullish Move On A Second-Quarter Beat — With Caveats

22 Of 30 Dow Stocks Are Up. 3M Is One of Those.
JNJ

Barrons.com

9 days ago

22 Of 30 Dow Stocks Are Up. 3M Is One of Those.

Johnson & Johnson (JNJ) Q2 2024 Earnings Call Transcript
JNJ

Motley Fool

9 days ago

Johnson & Johnson (JNJ) Q2 2024 Earnings Call Transcript

JNJ

MT Newswires

9 days ago

Stifel Raises Johnson & Johnson's Price Target to $160 From $155

Johnson And Johnson Continues To Focus On Medical Innovation
JNJ

Benzinga

9 days ago

Johnson And Johnson Continues To Focus On Medical Innovation

Small caps, biggest themes in the media landscape: Catalysts
JNJ

Yahoo Finance Video

9 days ago

Small caps, biggest themes in the media landscape: Catalysts

Chip stocks under pressure, pharmaceuticals rise: Morning Brief
JNJ

Yahoo Finance Video

9 days ago

Chip stocks under pressure, pharmaceuticals rise: Morning Brief

JNJ posts Q2 earnings beat, but slashes 2024 profit forecast
JNJ

Yahoo Finance Video

9 days ago

JNJ posts Q2 earnings beat, but slashes 2024 profit forecast

These Stocks Are Moving the Most Today: Nvidia, Super Micro, ASML, TSMC, J&J, GitLab, Five Below, and More
JNJ

Barrons.com

9 days ago

These Stocks Are Moving the Most Today: Nvidia, Super Micro, ASML, TSMC, J&J, GitLab, Five Below, and More

Johnson & Johnson Earnings Top, But Dow Stock Lowers Guidance
JNJ

Investor's Business Daily

9 days ago

Johnson & Johnson Earnings Top, But Dow Stock Lowers Guidance

Dow Jones Futures Fall, Chips Tumble On ASML Earnings, China Curbs, Trump Comments
JNJ

Investor's Business Daily

9 days ago

Dow Jones Futures Fall, Chips Tumble On ASML Earnings, China Curbs, Trump Comments

Johnson & Johnson's Q2 Earnings: Revenue And Profit Beat On Strong Pharma Sales, Annual Profit Outlook Lowered On M&A Costs
JNJ

Benzinga

9 days ago

Johnson & Johnson's Q2 Earnings: Revenue And Profit Beat On Strong Pharma Sales, Annual Profit Outlook Lowered On M&A Costs

5 Things to Know Before the Stock Market Opens
JNJ

Investopedia

9 days ago

5 Things to Know Before the Stock Market Opens

Johnson & Johnson (JNJ) Beats Q2 Earnings and Revenue Estimates
JNJ

Zacks

10 days ago

Johnson & Johnson (JNJ) Beats Q2 Earnings and Revenue Estimates

JNJ

MT Newswires

10 days ago

Johnson & Johnson Q2 Adjusted Earnings, Revenue Rise; Lowers Full-Year Earnings Guidance

Dow Jones Futures: Bullish Market Rotation Continues; ASML On Tap With 5 Stocks In Buy Zones
JNJ

Investor's Business Daily

10 days ago

Dow Jones Futures: Bullish Market Rotation Continues; ASML On Tap With 5 Stocks In Buy Zones

United Airlines, JNJ earnings, housing data: What to Watch
JNJ

Yahoo Finance Video

10 days ago

United Airlines, JNJ earnings, housing data: What to Watch

Johnson & Johnson (JNJ): Did this Dividend Stock Outperform During the Last Quarter?
JNJ

Insider Monkey

10 days ago

Johnson & Johnson (JNJ): Did this Dividend Stock Outperform During the Last Quarter?

Johnson & Johnson Earnings Are Coming. It Took Steps to Put Its Talc Issues Behind It.
JNJ

Barrons.com

10 days ago

Johnson & Johnson Earnings Are Coming. It Took Steps to Put Its Talc Issues Behind It.

J&J, Abbott and Intuitive start medtech earnings season
JNJ

MedTech Dive

11 days ago

J&J, Abbott and Intuitive start medtech earnings season

Dow Closes at New High as Q2 Earnings Season Heats Up
JNJ

Zacks

11 days ago

Dow Closes at New High as Q2 Earnings Season Heats Up

J&J (JNJ) Stock Before Q2 Earnings: To Buy or Not to Buy?
JNJ

Zacks

11 days ago

J&J (JNJ) Stock Before Q2 Earnings: To Buy or Not to Buy?

Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid
JNJ

Zacks

11 days ago

Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid

Johnson & Johnson's (NYSE:JNJ) 6.0% CAGR outpaced the company's earnings growth over the same five-year period
JNJ

Simply Wall St.

11 days ago

Johnson & Johnson's (NYSE:JNJ) 6.0% CAGR outpaced the company's earnings growth over the same five-year period

NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors
JNJ

GlobeNewswire

11 days ago

NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
JNJ

Motley Fool

12 days ago

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

2 Healthcare Stocks to Buy Hand Over Fist This Month
JNJ

Motley Fool

12 days ago

2 Healthcare Stocks to Buy Hand Over Fist This Month

Netflix results, retail sales, and a chip update: What to watch this week
JNJ

Yahoo Finance

12 days ago

Netflix results, retail sales, and a chip update: What to watch this week

What To Expect in the Markets This Week
JNJ

Investopedia

13 days ago

What To Expect in the Markets This Week

3 High-Yield Dividend Stocks That Still Look Like Bargains
JNJ

Motley Fool

13 days ago

3 High-Yield Dividend Stocks That Still Look Like Bargains

3 Key Earnings Reports to Watch Next Week
JNJ

Zacks

14 days ago

3 Key Earnings Reports to Watch Next Week

Unlocking Q2 Potential of Johnson & Johnson (JNJ): Exploring Wall Street Estimates for Key Metrics
JNJ

Zacks

14 days ago

Unlocking Q2 Potential of Johnson & Johnson (JNJ): Exploring Wall Street Estimates for Key Metrics

J&J asserts its place in atopic dermatitis space with Yellow Jersey acquisition
JNJ

Pharmaceutical Technology

15 days ago

J&J asserts its place in atopic dermatitis space with Yellow Jersey acquisition

Johnson & Johnson (NYSE:JNJ) is largely controlled by institutional shareholders who own 71% of the company
JNJ

Simply Wall St.

15 days ago

Johnson & Johnson (NYSE:JNJ) is largely controlled by institutional shareholders who own 71% of the company

JNJ

MT Newswires

15 days ago

Johnson & Johnson Completes Acquisition of Yellow Jersey Therapeutics

Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
JNJ

Business Wire

16 days ago

Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26

3 Magnificent Dow Stocks That Are No-Brainer Buys for the Second Half of 2024
JNJ

Motley Fool

16 days ago

3 Magnificent Dow Stocks That Are No-Brainer Buys for the Second Half of 2024

Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know
JNJ

Zacks

16 days ago

Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know

Will Q2 Earnings Power Dow ETFs?
JNJ

Zacks

16 days ago

Will Q2 Earnings Power Dow ETFs?

Energised US market opportunity for pulsed field ablation
JNJ

Medical Device Network

16 days ago

Energised US market opportunity for pulsed field ablation

Johnson & Johnson (JNJ): One of the Best Blue Chip Dividend Stocks Right Now According to Hedge Funds?
JNJ

Insider Monkey

17 days ago

Johnson & Johnson (JNJ): One of the Best Blue Chip Dividend Stocks Right Now According to Hedge Funds?

JNJ

MT Newswires

18 days ago

Emergent Biosolutions, Johnson & Johnson Settle Dispute Over COVID-19 Vaccine Manufacturing

Long-Term Dividend Growth And Recent Hikes: Johnson & Johnson, Oshkosh, And ManpowerGroup
JNJ

Benzinga

18 days ago

Long-Term Dividend Growth And Recent Hikes: Johnson & Johnson, Oshkosh, And ManpowerGroup

Johnson & Johnson: An Exploration into Its Intrinsic Value
JNJ

GuruFocus.com

18 days ago

Johnson & Johnson: An Exploration into Its Intrinsic Value

J&J (JNJ) Trades Below 200 & 50-Day Moving Averages: Buy the Dip?
JNJ

Zacks

21 days ago

J&J (JNJ) Trades Below 200 & 50-Day Moving Averages: Buy the Dip?

3 High-Yield Dividend Stocks/ETFs to Buy Hand Over Fist in July
JNJ

Motley Fool

23 days ago

3 High-Yield Dividend Stocks/ETFs to Buy Hand Over Fist in July

JNJ

MT Newswires

23 days ago

Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer

How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin
JNJ

Investor's Business Daily

23 days ago

How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin

Health Canada Authorizes RYBREVANT® (amivantamab) in Combination with Carboplatin and Pemetrexed as the Only Targeted First-line Treatment Approved for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
JNJ

CNW Group

23 days ago

Health Canada Authorizes RYBREVANT® (amivantamab) in Combination with Carboplatin and Pemetrexed as the Only Targeted First-line Treatment Approved for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Beacon raises $170M for eye gene therapy; J&J confirms Carvykti survival benefit
JNJ

BioPharma Dive

23 days ago

Beacon raises $170M for eye gene therapy; J&J confirms Carvykti survival benefit

Johnson & Johnson gains FDA and EC approvals for TB treatment
JNJ

Pharmaceutical Technology

24 days ago

Johnson & Johnson gains FDA and EC approvals for TB treatment

Johnson & Johnson reports data from Phase III multiple myeloma treatment trial
JNJ

Clinical Trials Arena

24 days ago

Johnson & Johnson reports data from Phase III multiple myeloma treatment trial

Share on Social Networks: